Vaccine News and Research

Latest Vaccine News and Research

Generex Biotechnology receives Australian patent for vaccine technology to fight cancer and pandemic influenza

Generex Biotechnology announced today that its wholly owned subsidiary, Antigen Express, has received Australian Patent No. 778115 titled "Hybrid Peptides Modulate the Immune Response." Antigen Express is designing and testing such vaccine peptides for the control of cancer and infectious diseases with a particular focus on the pandemic H5N1 influenza, which has been reported in South East Asia.

26 Apr 2005

How Ebola virus infects cells - discovery

Ebola virus reproduction in laboratory-grown cells is severely hampered by enzyme-inhibiting chemicals, and these chemicals deserve further study as possible treatments for Ebola virus infections in humans, report scientists supported in part by the National Institute of Allergy and Infectious Diseases (NIAID).

23 Apr 2005

Launching of Vaccination Week in the Americas

The Pan American Health Organization, PAHO, together with the governments of the United States, Mexico and Canada, will hold a press conference Monday, April 25 at 10 a.m. at the National Press Club to launch Vaccination Week in the Americas, a multi-country immunization campaign.

23 Apr 2005

Aging population correlates with a switch from acute infectious diseases to chronic diseases as the major cause of morbidity and mortality

Some diseases like ulcers and certain types of cancer, once thought to be primarily related to lifestyle factors, are now known to be caused by microorganisms, and many more syndromes, including some psychiatric conditions, may have a connection to infection, according to a report released today by the American Academy of Microbiology.

22 Apr 2005

It will be at least a decade before a malaria vaccine is available

A seminar on malaria in this week’s issue of The Lancet states that it will be at least a decade before a vaccine for the disease will be ready for widespread use and emphasises the need to expand the use of existing control methods.

21 Apr 2005

Missing samples of deadly flu strain now found

World Health Organization (WHO) officials say that all but one of the deadly flu virus samples mistakenly sent to labs outside the United States have been destroyed.

20 Apr 2005

Clinical study of MDX-010/MDX-1379 combination shows durable responses in patients with metastatic melanoma

Medarex, Inc. and Bristol-Myers Squibb Company announced today that complete or partial responses in seven of 56 patients with metastatic melanoma showed durability ranging from four months to the longest still ongoing at over 34 months, with five of the seven responses ongoing for more than two years.

20 Apr 2005

Concern over H2N2 freeze-dried powder being available over the Internet

The World Health Organization fears that a global pandemic could occur should the H2N2 virus, the "Asian flu" strain of 1957, be unwittingly released, the virus which was mistakenly included in routine test kits and sent to 61 laboratories in 18 countries outside the United States.

19 Apr 2005

Experimental vaccine targeting West Nile virus

A small trial testing the safety of an experimental vaccine targeting West Nile virus (WNV) opened today at the National Institutes of Health's (NIH) Clinical Center in Bethesda, MD.

19 Apr 2005

Rates of cervical cancer could jump fourfold to a million a year by 2050

Deaths from cervical cancer could jump fourfold to a million a year by 2050, mainly in developing countries. This could be prevented by soon-to-be-approved vaccines against the virus that causes most cases of cervical cancer- but there are signs that opposition to the vaccines might lead to many preventable deaths. The trouble is that the human papilloma virus (HPV) is sexually transmitted.

13 Apr 2005

Mumps jabs may run out in Ireland

GPs in Northern Ireland are warning that following a mumps outbreak among teenagers and young adults, supplies of the MMR vaccine in Northern Ireland could be running out. Family doctors have been asked to return any unused supplies so these can be re-distributed.

12 Apr 2005

New medical uses for the Kunjin virus

Queensland Government scientists at the Department of Health Services have collaborated with scientists at the University of Queensland (UQ) and The Queensland Institute of Medical Research (QIMR) to discover new medical uses for the Kunjin virus.

12 Apr 2005

Protection against 12 different communicable diseases available for infants and toddlers

In recognition of National Infant Immunization Week (April 24, 2005 through April 30, 2005), the Nassau County Department of Health urges all parents to ensure that their infants and toddlers are fully protected from the following vaccine preventable diseases: diphtheria, tetanus, pertussis (whooping cough), poliomyelitis, measles, mumps, rubella, hepatitis B, haemophilus influenza (meningitis), varicella (chickenpox), pneumococcal disease and influenza.

12 Apr 2005

Vaccine against the virus that causes cervical cancer and genital warts shows promise

A vaccine against the virus that causes cervical cancer and genital warts could reduce persistent infection and disease by 90%, suggest the results of a randomised trial published online by The Lancet Oncology.

12 Apr 2005

Locals resist efforts to control the worst ever outbreak of Marburg

The World Health Organisation (WHO) have sent communications experts into Uige, the epicentre of the outbreak of Marburg epidemic to help Health experts in the fight to contain and eradicate the killer virus. It is hoped they will send a clear message to Angolans to take the necessary measures to fight the virus.

12 Apr 2005

Now revealed that Salk polio vaccine was a team effort

The cure for polio came as a result of the collaboration between Thomas Francis Jr. and Jonas Salk.

10 Apr 2005

UAB reaction to Lancet study on human papilloma virus (HPV)

The prominent British medical journal Lancet published results of a clinical trial on a vaccine for human papilloma virus (HPV) The virus is a leading cause of cervical cancer and genital warts.

10 Apr 2005

Attacks on WHO staff - progress on Marburg epidemic halted

The World Health Organization (WHO) has suspended its efforts to contain the outbreak of the deadly Marburg virus in Angola, in the northern province of Uige, after staff in their mobile surveillance vehicles have been attacked.

10 Apr 2005

Race to market cancer vaccine

In a race to market the first vaccine against the virus that causes cervical cancer and genital warts drug manufacturers Merck & Co Inc. and GlaxoSmithKline plc are in head-to-head competition.

7 Apr 2005

Vaccine against cervical cancer and genital warts looks hopeful

More than two thirds of sexually active women will become infected with human papillomavirus (HPV) during their lifetime. HPV causes around 470 000 cases of cervical cancer each year and even though most cases of cervical cancer occur in the developing world, where cervical screening programmes are in the main non-existent, in Europe and the US 35000 women die from the disease every year.

6 Apr 2005